Pharmaloz Manufacturing to increase plant capacity by over 50%

Pharmaloz Manufacturing, a subsidiary of ProPhase Labs, is expanding its plant capacity by over 50% through automation equipment and efficiencies, raising annual production capability from below $10 million to over $15 million.

“PMI recently acquired cutting-edge automation equipment and, with other operating efficiencies, is set to escalate plant capacity by over 50%”biospace.com

• 1 source
• biospace.comPharmaloz Manufacturing Accelerates Expansion, Improves Pricing, Boosts Profitability and Secures New ContractsGabrielle MassonJan 23, 2024

Summarized from public sources; check the original articles before acting on it.